NCIs FY95 Bypass To Justify $3.47 Billion, includes $490 million For Breast Cancer Research
In Brief: san Antonio’s ICRC Gets a New Name, SACI; Blum Is deputy Oncology Director At Kaplan
Who Writes NCI’s bypass Budget anyway>? Editor’s name Revealed
NCAB Votes To Return P01 Review To Pre-1987 System, Two-Tier Review
DCPC Advisors Consider Asking DRG For Section On Prevention & Control
Breast Cancer Coalition Plans Petition Urging Comprehensive Strategy
Low-Income Women Lack Mammography Access: Survey
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
